TF and cancer: Numerous studies [73] describing the reactivity of KP1019 and NKP-1339 with Tf, as well as the accumulation of the compounds in cancer cells, support the hypothesis that selective delivery of these Ru(III) compounds occurs into the malignant tissue via Tf followed by cellular uptake via Tf receptors.